Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $132,537 | 7 | 99.5% |
| Food and Beverage | $379.50 | 5 | 0.3% |
| Travel and Lodging | $249.08 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agilent Technologies, Inc. | $132,786 | 8 | $0 (2023) |
| Genentech USA, Inc. | $200.85 | 2 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $90.48 | 1 | $0 (2019) |
| BAXTER HEALTHCARE | $60.46 | 1 | $0 (2019) |
| Alnylam Pharmaceuticals Inc. | $27.71 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $6,041 | 5 | Agilent Technologies, Inc. ($6,041) |
| 2022 | $27.71 | 1 | Alnylam Pharmaceuticals Inc. ($27.71) |
| 2021 | $110,953 | 1 | Agilent Technologies, Inc. ($110,953) |
| 2020 | $15,792 | 2 | Agilent Technologies, Inc. ($15,792) |
| 2019 | $150.94 | 2 | Ipsen Biopharmaceuticals, Inc ($90.48) |
| 2018 | $76.12 | 1 | Genentech USA, Inc. ($76.12) |
| 2017 | $124.73 | 1 | Genentech USA, Inc. ($124.73) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $2,448.00 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 12/08/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,071.00 | General |
| 12/08/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $76.50 | General |
| 05/25/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 01/09/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $2,295.00 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 07/02/2022 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Genetic Disease | ||||||
| 01/17/2021 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $110,953.13 | General |
| 12/19/2020 | Agilent Technologies, Inc. | HER2 IQFISH (Device) | Travel and Lodging | In-kind items and services | $249.08 | General |
| Category: pharmDX | ||||||
| 11/29/2020 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $15,542.98 | General |
| 10/25/2019 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug) | Food and Beverage | In-kind items and services | $90.48 | General |
| Category: Oncology/Endocrinology | ||||||
| 10/15/2019 | BAXTER HEALTHCARE | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $60.46 | General |
| Category: Surgical Care | ||||||
| 11/29/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $76.12 | General |
| 11/30/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $124.73 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 16 | 1,336 | 1,702 | $143,334 | $56,034 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 410 | 612 | $51,408 | $20,031 | 39.0% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2020 | 40 | 40 | $15,760 | $6,353 | 40.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 155 | 174 | $14,616 | $5,630 | 38.5% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 63 | 76 | $5,928 | $2,352 | 39.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2020 | 17 | 31 | $5,766 | $2,280 | 39.5% |
| 88360 | Microscopic genetic analysis of tumor | Office | 2020 | 16 | 55 | $5,170 | $2,087 | 40.4% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 65 | 68 | $5,304 | $2,055 | 38.7% |
| 88112 | Cell examination of specimen | Office | 2020 | 77 | 79 | $4,898 | $1,914 | 39.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2020 | 24 | 24 | $4,464 | $1,708 | 38.3% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2020 | 22 | 23 | $3,630 | $1,399 | 38.5% |
| 88341 | Special stained specimen slides to examine tissue | Office | 2020 | 23 | 49 | $3,136 | $1,241 | 39.6% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 47 | 49 | $3,136 | $1,187 | 37.9% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2020 | 16 | 18 | $2,844 | $1,123 | 39.5% |
| 88333 | Pathology examination of tissue specimen during surgery | Facility | 2020 | 16 | 17 | $2,379 | $909.94 | 38.2% |
| 88344 | Special stained specimen slides to examine tissue | Office | 2020 | 15 | 26 | $2,236 | $882.39 | 39.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2020 | 65 | 69 | $1,794 | $671.18 | 37.4% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2020 | 18 | 19 | $1,520 | $588.25 | 38.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2020 | 51 | 54 | $1,512 | $573.21 | 37.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2020 | 46 | 52 | $1,352 | $522.61 | 38.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2020 | 14 | 21 | $1,218 | $498.58 | 40.9% |
| 88112 | Cell examination of specimen | Facility | 2020 | 16 | 19 | $1,178 | $451.27 | 38.3% |
| 88360 | Microscopic genetic analysis of tumor | Facility | 2020 | 11 | 11 | $1,034 | $397.60 | 38.5% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2020 | 18 | 18 | $972.00 | $369.27 | 38.0% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2020 | 14 | 15 | $871.00 | $341.17 | 39.2% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Office | 2020 | 15 | 21 | $588.00 | $233.13 | 39.6% |
About Dr. Oliver Press, M.D
Dr. Oliver Press, M.D is a Cytopathology healthcare provider based in San Luis Obispo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2011. The National Provider Identifier (NPI) number assigned to this provider is 1235421710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Oliver Press, M.D has received a total of $133,165 in payments from pharmaceutical and medical device companies, with $6,041 received in 2023. These payments were reported across 13 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($132,537).
As a Medicare-enrolled provider, Press has provided services to 1,336 Medicare beneficiaries, totaling 1,702 services with total Medicare billing of $56,034. Data is available for 1 year (2020–2020), covering 27 distinct procedure/service records.
Practice Information
- Specialty Cytopathology
- Other Specialties Anatomic Pathology & Clinical Pathology, Student in an Organized Health Care Education/Training Program
- Location San Luis Obispo, CA
- Active Since 05/03/2011
- Last Updated 06/21/2024
- Taxonomy Code 207ZC0500X
- Entity Type Individual
- NPI Number 1235421710
Products in Payments
- PD-L1 IHC 28-8 PHARMDX (Device) $4,743
- HER2 IQFISH (Device) $249.08
- SOMATULINE DEPOT (Drug) $90.48
- TISSEEL (Biological) $60.46
- GIVLAARI (Drug) $27.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cytopathology Doctors in San Luis Obispo
Dr. Zoltan Nagymanyoki, M.d., Ph.d, M.D., PH.D
Cytopathology — Payments: $248.04
Dr. Brandie Firetag, Md, MD
Cytopathology — Payments: $140.17
Robert Monroe, M.d, M.D
Cytopathology — Payments: $60.00
Cynthia Douglas, M.d, M.D
Cytopathology
David Lawrence, M.d, M.D
Cytopathology